View all data FOR FREE!
Create an account today, no credit card required.
| Issue Type | XXXX |
|---|---|
| Country | United States |
| Industry | XXXX |
| Region | XXXX |
| Maturity Date | 2035-07-30 |
| Par Value | |
| Callable | XXXX |
| Next Call Date | XXXX |
| Call Type | XXXX |
| Call Price (%) | XXXX |
| Series | XXXX |
| Class | XXXX |
| Maturity Structure | XXXX |
| Amount Outstanding (mil) | 318.22 |
| Coupon | 5.5 |
|---|---|
| Coupon Type | XXXX |
| Coupon Frequency | XXXX |
| First Coupon Date | XXXX |
| Last Coupon Date | XXXX |
| Sinking Fund | XXXX |
|---|---|
| Security | XXXX |
| Subordination | XXXX |
| Debt Type | XXXX |
| Issue Date | XXXX |
|---|---|
| Dated Date | XXXX |
| Issue Size (mil) | 318.22 |
| Min. Piece | XXXX |
| Min. Increment | XXXX |
This Bayer US Finance II LLC corporate note has a 5.50% fixed rate coupon paid on a semi-annual basis. It was issued on July 12, 2018 with an issue size of 318.22 million USD and matures on July 30, 2035 with a last coupon date of January 30, 2035. |
Bayer US Finance II LLC, founded in 2002 and headquartered in Whippany, New Jersey, serves as a financing arm for Bayer AG, the global life sciences company. The primary purpose of the entity is to support the funding needs of its parent company, facilitating various financial operations across its extensive portfolio. Key financial services include structuring debt instruments and managing liquidity for Bayer's subsidiaries within the United States.